Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47.12	71.34	88.4	53.64	96.45	65.08
Short-Term Investments	143.95	156.62	183.46	355.95	290.61	219.36
Cash & Short-Term Investments	191.07	227.96	271.86	409.59	387.06	284.44
Cash Growth	-42.20%	-16.15%	-33.63%	5.82%	36.08%	180.89%
Accounts Receivable	115.12	73.07	25.81	8.46	-	-
Other Receivables	-	-	-	-	-	0.51
Receivables	115.12	73.07	25.81	8.46	-	0.51
Inventory	22.42	14.53	13.13	7.51	-	-
Prepaid Expenses	11.05	12.29	10.1	7.39	14.17	6.33
Restricted Cash	0.31	0.62	0.93	1.23	1.54	1.54
Other Current Assets	9.26	7.37	8.61	3.23	-	-
Total Current Assets	349.22	335.82	330.43	437.41	402.77	292.83
Property, Plant & Equipment	5.78	2.99	3.9	4.6	5.3	5.37
Other Intangible Assets	15.38	9.48	6.44	7.19	-	-
Other Long-Term Assets	0.6	0.6	0.6	0.08	0.08	0.08
Total Assets	370.98	348.89	341.37	449.27	408.15	298.27
Accounts Payable	5.8	14.22	11.99	8.83	7.35	7.14
Accrued Expenses	92.98	65.97	33.94	28.32	25.54	15.29
Current Portion of Leases	-	0.82	0.74	0.66	0.43	-
Other Current Liabilities	-	-	-	-	-	0.18
Total Current Liabilities	99.77	81.01	46.67	37.81	33.33	22.6
Long-Term Debt	107.5	107.2	201.8	197.77	72.35	-
Long-Term Leases	5.28	2.56	3.38	4.12	4.77	4.96
Other Long-Term Liabilities	0.36	0.57	0.85	-	0.03	0.08
Total Liabilities	212.9	191.35	252.7	239.69	110.48	27.65
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,314	1,279	1,071	930.43	706.23	472.57
Retained Earnings	-1,155	-1,122	-981.9	-719.76	-408.31	-201.95
Comprehensive Income & Other	-0.06	-0.01	0	-1.09	-0.26	-0
Total Common Equity	158.07	157.54	88.67	209.58	297.68	270.62
Shareholders' Equity	158.07	157.54	88.67	209.58	297.68	270.62
Total Liabilities & Equity	370.98	348.89	341.37	449.27	408.15	298.27
Total Debt	113.77	110.59	205.92	202.54	77.56	4.96
Net Cash (Debt)	77.29	117.37	65.95	207.05	309.5	279.48
Net Cash Growth	-36.84%	77.98%	-68.15%	-33.10%	10.74%	176.83%
Net Cash Per Share	0.61	0.97	0.95	3.76	6.26	7.84
Filing Date Shares Outstanding	122.49	118.64	96.81	61.08	50.38	50.08
Total Common Shares Outstanding	120.29	117.85	96.79	61.04	50.26	43.34
Working Capital	249.45	254.81	283.76	399.6	369.45	270.22
Book Value Per Share	1.31	1.34	0.92	3.43	5.92	6.24
Tangible Book Value	142.7	148.06	82.23	202.39	297.68	270.62
Tangible Book Value Per Share	1.19	1.26	0.85	3.32	5.92	6.24
Machinery	-	1.93	1.79	1.36	1.12	0.52
Construction In Progress	-	-	-	-	-	0.3
Leasehold Improvements	-	1.57	1.57	1.57	1.57	1.28

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q